Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19

NCT04891250 is registered in ClinicalTrials.gov with Centre for Infectious Disease Research in Zambia as lead sponsor.

NCT NCT04891250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04891250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19
Lead sponsor
Centre for Infectious Disease Research in Zambia
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2021
Completion date
June 30, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ivermectin, sars-cov-2